Publication | Open Access
AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
24
Citations
27
References
2020
Year
In summary, our study showed that AHNAK2 might be a novel biomarker in LUAD and revealed the potential mechanism of AHNAK2 in LUAD progression which could provide new insights for target therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1